# Eva Lonn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eva-lonn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,317 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 82 |
| i10-index | 214 |
| Last Known Institution | Çevre, Şehircilik ve İklim Değişikliği Bakanlığı |
| OpenAlex ID | https://openalex.org/A5016752955 |
| ORCID iD | https://orcid.org/0000-0002-0156-6730 |
| Works | 311 |

## Researcher papers

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult](https://scholariq.org/papers/2016-canadian-cardiovascular-society-guidelines-for-the-management-of/)
- [2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults](https://scholariq.org/papers/2021-canadian-cardiovascular-society-guidelines-for-the-management-of/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction](https://scholariq.org/papers/common-carotid-intima-media-thickness-measurements-in-cardiovascular-risk/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk](https://scholariq.org/papers/carotid-intima-media-thickness-progression-as-surrogate-marker-for/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Çevre, Şehircilik ve İklim Değişikliği Bakanlığı](https://scholariq.org/institutions/cevre-sehircilik-ve-iklim-degisikligi-bakanl-g/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
